MicroRNA-486-3p Regulates γ-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lulli, Valentina ^a   Romania, Paolo ^a,b   Morsilli, Ornella ^a   Cianciulli, Paolo ^c   Gabbianelli, Marco ^a   Testa, Ugo ^a   Giuliani, Alessandro ^a   Marziali, Giovanna ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HEMOGLOBIN GAMMA CHAIN; MICRORNA; MICRORNA 486 3P; PROTEIN BCL11A; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; ERYTHROID CELL; FLOW CYTOMETRY; GAMMA GLOBIN GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PLASMID; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; ANTIGENS, CD34; BASE PAIRING; BASE SEQUENCE; BETA-THALASSEMIA; CARRIER PROTEINS; CELL LINE; CELL LINEAGE; CELLS, CULTURED; ERYTHROID CELLS; FETAL HEMOGLOBIN; GAMMA-GLOBINS; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GENOTYPE; HEMATOPOIETIC STEM CELLS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; RNA ISOFORMS;

EID: 84875914831     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060436     Document Type: Article

References (56)

1. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
2. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
3. Guo H, Ingolia NT, Weissman JS, Bartel DP, (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835-40.
4. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight. Nat Rev Genet 9: 102-114.
5. Garzon R, Croce CM, (2008) MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15: 352-358.
6. Bissels U, Bosio A, Wagner W, (2012) MicroRNAs are shaping the hematopoietic landscape. Haematologica 97: 160-7.
7. Byon JC, Papayannopoulou T, (2012) MicroRNAs: Allies or foes in erythropoiesis? J Cell Physiol 227: 7-13.
8. Lawrie CH, (2010) microRNA expression in erythropoiesis and erythroid disorders. Br J Haematol 150: 144-51.
9. Rasmussen KD, Simmini S, Abreu-Goodger C, Bartonicek N, Di Giacomo M, et al. (2010) The miR-144/451 locus is required for erythroid homeostasis. J Exp Med 207: 1351-8.
10. Rasmussen KD, O'Carroll D, (2011) The miR-144/451eGFP allele, a novel tool for resolving the erythroid potential of hematopoietic precursors. Blood 118: 2988-92.
11. Lu J, Guo S, Ebert BL, Zhang H, Peng X, et al. (2008) MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 14: 843-853.
12. Felli N, Fontana L, Pelosi E, Botta R, Bonci D, et al. (2005) MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 102: 18081-6.
13. Felli N, Pedini F, Romania P, Biffoni M, Morsilli O, et al. (2009) MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 94: 479-86.
14. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
15. Bauer DE, Kamran SC, Orkin SH, (2012) Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders. Blood 120: 2945-53.
16. Sankaran VG, Xu J, Orkin SH, (2010) Advances in the understanding of haemoglobin switching. http://www.ncbi.nlm.nih.gov/pubmed/20201948 Br J Haematol 149: 181-94.
17. Bianchi N, Zuccato C, Lampronti I, Borgatti M, Gambari R, (2009) Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Rep 42: 493-9.
18. Noh SJ, Miller SH, Lee YT, Goh SH, Marincola FM, et al. (2009) Let-7 microRNAs are developmentally regulated in circulating human erythroid cells. J Transl Med 7: 98.
19. Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, et al. (2010) Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica 95: 1253-60.
20. Sankaran VG, Menne TF, Šćepanović D, Vergilio JA, Ji P, et al. (2011) MicroRNA-15a and-16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci USA 108: 1519-24.
21. Azzouzi I, Moest H, Winkler J, Fauchère JC, Gerber AP, et al. (2011) MicroRNA-96 directly inhibits γ-globin expression in human erythropoiesis. PLoS One 6(7): e22838.
22. Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, et al. (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322: 1839-42.
23. Sankaran VG, Xu J, Ragoczy T, Ippolito GC, Walkley CR, et al. (2009) Developmental and species-divergent globin switching are driven by BCL11A. Nature 460: 1093-7.
24. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, et al. (2001) The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98: 3413-20.
25. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, et al. (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4: 525-32.
26. Thein SL, Menzel S, Peng X, Best S, Jiang J, et al. (2007) Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci USA 104: 11346-51.
27. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, et al. (2003) Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 22: 4478-88.
28. Jiang J, Best S, Menzel S, Silver N, Lai MI, et al. (2006) cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 108: 1077-83.
29. Sankaran VG (2011) Target therapeutic strategies for fetal hemoglobin induction. Hematology Am Soc Hematol Educ Program. 2011; 459-65. Review.
30. Xu J, Sankaran VG, Ni M, Menne TF, Puram RV, et al. (2010) Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev 24: 783-98.
31. Felli N, Cianetti L, Pelosi E, Carè A, Liu CG, et al. (2010) Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states. BMC Syst Biol 16: 4-85.
32. Gabbianelli M, Testa U, Massa A, Pelosi E, Sposi NM, et al. (2000) Hemoglobin switching in unicellular erythroid culture of sibling erythroid burst-forming units: kit ligand induces a dose dependent fetal hemoglobin reactivation potentiated by sodiumbutyrate. Blood 95: 3555-3561.
33. Gabbianelli M, Morsilli O, Massa A, Pasquini L, Cianciulli P, et al. (2008) Effective erythropoiesis and HbF reactivation induced by kit ligand in beta-thalassemia. Blood 111: 421-9.
34. Leone L, Monteleone M, Gabutti V, Amione C, (1985) Reversed-phase high-performance liquid chromatography of human haemoglobin chains. J Chromatogr 321: 407-419.
35. Merkerova M, Vasikova A, Belickova M, Bruchova H, (2010) MicroRNA expression profiles in umbilical cord blood cell lineages. Stem Cells Dev 19: 17-26.
36. Liu H, Ippolito GC, Wall JK, Niu T, Probst L, et al. (2006) Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells. Mol Cancer 16: 5-18.
37. Sripichai O, Kiefer CM, Bhanu NV, Tanno T, Noh SJ, et al. (2009) Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood 114: 2299-306.
38. Reverter A, Chan EKF, (2008) Combining partial correlation and an information theory approach to the reversed engineering of gene co-expression networks. Bioinformatics 24: 2491-2497.
39. Menzel S, Garner C, Gut I, Matsuda F, Yamaguchi M, et al. (2007) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet 39: 1197-9.
40. Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, et al. (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA 105: 1620-5.
41. Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, et al. (2010) Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci USA 107: 4218-23.
42. Oh HK, Tan AL, Das K, Ooi CH, Deng NT, et al. (2011) Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer. Clin Cancer Res 17: 2657-67.
43. Gallagher PG, Romana M, Tse WT, Lux SE, Forget BG, (2000) The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter. Blood 96: 1136-43.
44. Zhou D, Birkenmeier CS, Williams MW, Sharp JJ, Barker JE, et al. (1997) Small, membrane-bound, alternatively spliced forms of ankyrin 1 associated with the sarcoplasmic reticulum of mammalian skeletal muscle. J Cell Biol 136: 621-31.
45. Navon R, Wang H, Steinfeld I, Tsalenko A, Ben-Dor A, et al. (2009) Novel rank-based statistical methods reveal microRNAs with differential expression in multiple cancer types. PLoS One 4: e8003.
46. Yu J, Li A, Hong SM, Hruban RH, Goggins M, (2012) MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias. Clin Cancer Res 18: 981-92.
47. Ali S, Saleh H, Sethi S, Sarkar FH, Philip PA (2012) MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br J Cancer doi: 10.1038/bjc.2012.383.
48. Hummel R, Wang T, Watson DI, Michael MZ, Van der Hoek M, et al. (2011) Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol Rep Rep 26: 1011-7.
49. Mosakhani N, Sarhadi VK, Borze I, Karjalainen-Lindsberg ML, Sundström J, et al. (2012) MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 51: 1-9.
50. Tan X, Qin W, Zhang L, Hang J, Li B, et al. (2011) A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis. Clin Cancer Res 17: 6802-11.
51. Chan E, Patel R, Nallur S, Ratner E, Bacchiocchi A, et al. (2011) MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 10: 1845-52.
52. Konishi H, Ichikawa D, Komatsu S, Shiozaki A, Tsujiura M, et al. (2011) Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br J Cancer 106: 740-7.
53. Xu J, Peng C, Sankaran VG, Shao Z, Esrick EB, et al. (2011) Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334: 993-6.
54. Hall MA, Curtis DJ, Metcalf D, Elefanty AG, Sourris K, et al. (2003) The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci USA 100: 992-7.
55. Kiefer CM, Lee J, Hou C, Dale RK, Lee YT, et al. (2011) Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells. Blood 118: 6200-8.
56. Fu YF, Du TT, Dong M, Zhu KY, Jing CB, et al. (2009) Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis. Blood 113: 1340-9.